Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECASIS: Enteric Coated vs Plain Aspirin in Acute Ischemic Stroke
NCT04330872Phase 4Completed
- Sponsor
- Hamad Medical Corporation
- Start
- Aug 2019
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in ischemic stroke, sponsored by Hamad Medical Corporation. Started Aug 2019; status: completed.
02
Drugs
aspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04330872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04330872.